- Home
- VST vs GSK Comparison
VST vs GSK Comparison
Compare VST & GSK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VST
- GSK
- Stock Information
- Founded
- VST 1882
- GSK 1715
- Country
- VST United States
- GSK United Kingdom
- Employees
- VST N/A
- GSK N/A
- Industry
- VST Electric Utilities: Central
- GSK Biotechnology: Pharmaceutical Preparations
- Sector
- VST Utilities
- GSK Health Care
- Exchange
- VST Nasdaq
- GSK Nasdaq
- Market Cap
- VST 65.2B
- GSK 77.1B
- IPO Year
- VST N/A
- GSK N/A
- Fundamental
- Price
- VST $207.25
- GSK $40.36
- Analyst Decision
- VST Strong Buy
- GSK Hold
- Analyst Count
- VST 9
- GSK 2
- Target Price
- VST $199.44
- GSK N/A
- AVG Volume (30 Days)
- VST 4.1M
- GSK 3.8M
- Earning Date
- VST 11-06-2025
- GSK 10-29-2025
- Dividend Yield
- VST 0.43%
- GSK 4.04%
- EPS Growth
- VST 383.82
- GSK N/A
- EPS
- VST 6.37
- GSK 1.13
- Revenue
- VST $18,508,000,000.00
- GSK $43,336,073,439.00
- Revenue This Year
- VST $20.55
- GSK $5.66
- Revenue Next Year
- VST $9.55
- GSK $5.13
- P/E Ratio
- VST $32.86
- GSK $35.38
- Revenue Growth
- VST 31.60
- GSK 0.59
- 52 Week Low
- VST $84.92
- GSK $31.72
- 52 Week High
- VST $217.90
- GSK $43.62
- Technical
- Relative Strength Index (RSI)
- VST 58.35
- GSK 54.57
- Support Level
- VST $202.01
- GSK $40.03
- Resistance Level
- VST $217.90
- GSK $41.53
- Average True Range (ATR)
- VST 7.55
- GSK 0.59
- MACD
- VST 2.11
- GSK -0.03
- Stochastic Oscillator
- VST 74.18
- GSK 58.28
About VST Vistra Corp.
Vistra Energy is one of the largest power producers and retail energy providers in the US. Following the 2024 Energy Harbor acquisition, Vistra owns 41 gigawatts of nuclear, coal, natural gas, solar, and energy storage assets. The proposed Lotus Partners acquisition would add 2.6 GW of natural gas generation. Its retail electricity business serves 5 million customers in 20 states, including almost a third of all Texas electricity consumers. Vistra emerged from the Energy Future Holdings bankruptcy as a stand-alone entity in 2016. It acquired Dynegy in 2018.
About GSK GSK plc (Each representing two)
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.